Otsuka Pharmaceutical Co., Ltd.
Clinical trials sponsored by Otsuka Pharmaceutical Co., Ltd., explained in plain language.
-
New cholesterol drug tested for patients who Can't tolerate statins
Disease control CompletedThis study tested a drug called ETC-1002 for people with high levels of 'bad' LDL cholesterol who cannot take or do not respond well to standard statin medications. For one year, researchers monitored 130 participants to see how safe the drug was and how well it lowered cholester…
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Large study monitors kidney disease drug in Real-World use
Disease control CompletedThis study monitored the safety and effectiveness of the drug tolvaptan in over 1,800 patients with ADPKD in Japan after it was approved for use. The main goal was to see how well the drug slowed the growth of kidney cysts in everyday medical practice and to track any side effect…
Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Feb 24, 2026 14:08 UTC
-
New pill aims to ease swelling for heart failure patients
Symptom relief CompletedThis study tested whether a new oral drug called OPC-131461 could help reduce excess fluid and swelling in people with congestive heart failure. It involved 157 hospitalized patients who were already taking standard water pills but still had fluid overload. Researchers compared f…
Phase: PHASE2 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
Scientists test if meals change how schizophrenia drug works
Knowledge-focused CompletedThis study checked whether eating a meal changes how the body absorbs a new, once-weekly version of the schizophrenia medication brexpiprazole. It involved 59 adults with stable schizophrenia who took the drug once while fasting and once after a high-fat meal. The main goal was t…
Phase: PHASE1 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC